Off-target effects in CRISPR-Cas genome editing for human therapeutics: Progress and challenges
- Nechama Kalter
- , Carla Fuster-García
- , Alfredo Silva
- , Víctor Ronco-Díaz
- , Stefano Roncelli
- , Giandomenico Turchiano
- , Jan Gorodkin
- , Toni Cathomen
- , Karim Benabdellah
- , Ciaran Lee
- , Ayal Hendel
- Bar-Ilan University
- University of Freiburg
- San Raffaele Telethon Institute for Gene Therapy
- Pfizer-University of Granada-Andalusian Regional Government Centre for Genomics and Oncological Research (GENYO)
- University of Copenhagen
- University College London
- AstraZeneca
Research output: Contribution to journal › Review article › peer-review